I think DI is deliberately kept out of the loop on events that if communicated in one off discussions could present broader problems. I think he shoots from the hip so to speak and is in the business of keeping investors invested and interested, not in the regulatory process business.
DI can’t confirm anything like DL that would put a narrow time frame on their knowledge of the data. As Anders clearly has shown the company must share a negative trial immediately. To confirm DL, would be in essence to confirm a positive TLD.
News 
Market Data 
Discover 
AI
